Statistics

Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)32

Select a period of time:

Number of views in the range

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)16

Views

Views
May 20245
June 20240
July 20240
August 20246
September 20242
October 20242
November 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
 

Top cities views

Views
Chicago3